TrialEuropean journal of heart failure2019

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.

Maurice Beghetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.